机构：[1]Capital Med Univ, Xuanwu Hosp, Dept Gen Surg, Beijing, Peoples R China首都医科大学宣武医院[2]Shandong First Med Univ, Shandong Prov Hosp, Dept Gastrointestinal Surg, Jinan, Shandong, Peoples R China
N(6)-methyladenosine (m6A) modification is the most abundant and prevalent internal modification in eukaryotic mRNAs. The role of m6A modification in cancer has become a hot research topic in recent years and has been widely explored. m6A modifications have been shown to regulate cancer occurrence and progression by modulating different target molecules. This paper reviews the recent research progress of m6A modifications in cancer and provides an outlook on future research directions, especially the development of molecularly targeted drugs.
基金：
National Natural Science Foundation of China [82470678]; Beijing Natural Science Foundation [7242069]; Beijing Hospital Administration Training Project [PX2023030]; Capital Medical Development and Research Special Project [Z201100005520090]
第一作者机构：[1]Capital Med Univ, Xuanwu Hosp, Dept Gen Surg, Beijing, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Xie Xiaozhou,Fang Zhen,Zhang Haoyu,et al.THE ROLE OF N(6)-METHYLADENOSINE (M6A) MODIFICATION IN CANCER: RECENT ADVANCES AND FUTURE DIRECTIONS[J].EXCLI JOURNAL.2025,24:113-150.doi:10.17179/excli2024-7935.
APA：
Xie, Xiaozhou,Fang, Zhen,Zhang, Haoyu,Wang, Zheng,Li, Jie...&Li, Fei.(2025).THE ROLE OF N(6)-METHYLADENOSINE (M6A) MODIFICATION IN CANCER: RECENT ADVANCES AND FUTURE DIRECTIONS.EXCLI JOURNAL,24,
MLA：
Xie, Xiaozhou,et al."THE ROLE OF N(6)-METHYLADENOSINE (M6A) MODIFICATION IN CANCER: RECENT ADVANCES AND FUTURE DIRECTIONS".EXCLI JOURNAL 24.(2025):113-150
